Neoadjuvant Listeria or Daratumumab in Prostate Cancer

Conditions:   Malignant Neoplasms of Male Genital Organs;   Prostate Cancer Intervention:   Drug: Daratumumab Sponsors:   M.D. Anderson Cancer Center;   Janssen-Cilag div. of Johnson&Johnson  SE Not yet recruiting - verified January 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials